Literature DB >> 21170593

17 beta-estradiol attenuates pressure overload-induced myocardial hypertrophy through regulating caveolin-3 protein in ovariectomized female rats.

Yu-Hong Cui1, Zhi Tan, Xiao-Dong Fu, Qiu-Ling Xiang, Jin-Wen Xu, Ting-Huai Wang.   

Abstract

Our findings indicate that in ovariectomized female rats abdominal aortic constriction led to significant increases in left ventricular mass, myocyte diameter and heart weight/body weight (HW/BW) value, and decreases in interventricular septal thickness at diastole (IVSd), left ventricular percent fractional shortening (FS) and ejection fraction (EF). These pathophysiological alterations were largely reversed by administration with 17β-estradiol for eight weeks. Furthermore, the enhanced expression of extracellular signal-regulated kinases 1/2 and decreased expression of caveolin-3 were found in left ventricle of AAC group. 17β-estradiol (E(2)) administration increased the expression of caveolin-3 and reduced the level of ERK phosphorylation in these pressure-overloaded rats. Moreover, in cultured neonatal rat cardiomyocytes, E(2) inhibited the hypertrophic response to angiotensin II. This effect was reinforced by the addition of extracellular signal-regulated kinases 1/2 inhibitor PD98059, but was impaired when the cells were pretreated with caveolae disruptor, methyl-β-cyclodextrin (M-β-CD). In conclusion, our data indicate that estrogen attenuates the hypertrophic response induced by pressure overload through down-regulation of extracellular signal-regulated kinases 1/2 phosphorylation and up-regulation of caveolin-3 expression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21170593     DOI: 10.1007/s11033-010-0630-0

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  40 in total

Review 1.  Caveolins, liquid-ordered domains, and signal transduction.

Authors:  E J Smart; G A Graf; M A McNiven; W C Sessa; J A Engelman; P E Scherer; T Okamoto; M P Lisanti
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

2.  Effect of hormone replacement therapy on left ventricular hypertrophy.

Authors:  W K Lim; B Wren; N Jepson; S Roy; G Caplan
Journal:  Am J Cardiol       Date:  1999-04-01       Impact factor: 2.778

Review 3.  Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention.

Authors:  F Chang; L S Steelman; J T Lee; J G Shelton; P M Navolanic; W L Blalock; R A Franklin; J A McCubrey
Journal:  Leukemia       Date:  2003-07       Impact factor: 11.528

4.  Estrogen receptor beta protects the murine heart against left ventricular hypertrophy.

Authors:  Fawzi A Babiker; Daniel Lips; Rainer Meyer; Els Delvaux; Pieter Zandberg; Ben Janssen; Guillaume van Eys; Christian Grohé; Pieter A Doevendans
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-04-20       Impact factor: 8.311

5.  Behavior of caveolae and caveolin-3 during the development of myocyte hypertrophy.

Authors:  Toshio Kikuchi; Naoki Oka; Akimasa Koga; Hiroshi Miyazaki; Haruya Ohmura; Tsutomu Imaizumi
Journal:  J Cardiovasc Pharmacol       Date:  2005-03       Impact factor: 3.105

6.  Reduction of caveolin-3 expression does not inhibit stretch-induced phosphorylation of ERK2 in skeletal muscle myotubes.

Authors:  Anne Claire Bellott; Kalpit C Patel; Thomas J Burkholder
Journal:  J Appl Physiol (1985)       Date:  2004-10-29

7.  Ventricular expression of a MLC-2v-ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice.

Authors:  J J Hunter; N Tanaka; H A Rockman; J Ross; K R Chien
Journal:  J Biol Chem       Date:  1995-09-29       Impact factor: 5.157

8.  Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo.

Authors:  P E Scherer; R Y Lewis; D Volonte; J A Engelman; F Galbiati; J Couet; D S Kohtz; E van Donselaar; P Peters; M P Lisanti
Journal:  J Biol Chem       Date:  1997-11-14       Impact factor: 5.157

9.  Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities.

Authors:  F Galbiati; J A Engelman; D Volonte; X L Zhang; C Minetti; M Li; H Hou; B Kneitz; W Edelmann; M P Lisanti
Journal:  J Biol Chem       Date:  2001-03-19       Impact factor: 5.157

Review 10.  Caveolae structure and function.

Authors:  Candice M Thomas; Eric J Smart
Journal:  J Cell Mol Med       Date:  2008-02-27       Impact factor: 5.310

View more
  5 in total

Review 1.  Computational models of cardiac hypertrophy.

Authors:  Kyoko Yoshida; Jeffrey W Holmes
Journal:  Prog Biophys Mol Biol       Date:  2020-07-21       Impact factor: 3.667

2.  Caveolin as a potential drug target for cardiovascular protection.

Authors:  Stephanie L Sellers; Andy E Trane; Pascal N Bernatchez
Journal:  Front Physiol       Date:  2012-07-18       Impact factor: 4.566

3.  Associations of plasma phospholipid omega-6 and omega-3 polyunsaturated Fatty Acid levels and MRI measures of cardiovascular structure and function: the multiethnic study of atherosclerosis.

Authors:  Jennifer S Anderson; Jennifer A Nettleton; W Gregory Hundley; Michael Y Tsai; Lyn M Steffen; Rozenn N Lemaitre; David Siscovick; João Lima; Martin R Prince; David Herrington
Journal:  J Nutr Metab       Date:  2011-08-22

4.  The Effect of Estrogen on Intracellular Ca2+ and Na+ Regulation in Heart Failure.

Authors:  Jahn M Firth; Hsiang-Yu Yang; Alice J Francis; Najah Islam; Kenneth T MacLeod
Journal:  JACC Basic Transl Sci       Date:  2020-09-02

Review 5.  Nutraceutical, Dietary, and Lifestyle Options for Prevention and Treatment of Ventricular Hypertrophy and Heart Failure.

Authors:  Mark F McCarty
Journal:  Int J Mol Sci       Date:  2021-03-24       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.